MediPharm Labs (TSE:LABS) Stock Price Down 5.6%

MediPharm Labs Corp. (TSE:LABSGet Rating)’s share price fell 5.6% during trading on Tuesday . The stock traded as low as C$0.09 and last traded at C$0.09. 85,145 shares changed hands during trading, a decline of 83% from the average session volume of 500,871 shares. The stock had previously closed at C$0.09.

MediPharm Labs Price Performance

The company has a quick ratio of 3.54, a current ratio of 5.23 and a debt-to-equity ratio of 2.11. The stock has a market capitalization of C$20.74 million and a price-to-earnings ratio of -0.41. The company’s 50-day simple moving average is C$0.08 and its 200 day simple moving average is C$0.08.

MediPharm Labs Company Profile

(Get Rating)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.

Read More

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.